BP-C1 in the treatment of patients with stage IV breast cancer: A randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase

• Main Authors: Stig Larsen, Kritiya Butthongkomvong, Alexey Manikhas, Ekaterina Trishkina, Elena Poddubuskaya, Marina Matrosova, Vichien Srimuninnimit, Steen Lindkær-Jensen
• Other Authors: Norwegian University of Life Science
• Format: Article
• Published: 2018
• Subjects: Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/34161
• Institution: Mahidol University

© 2014 Larsen et al. The aims were to compare the efficacy and tolerability of a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride (BP-C1) versus placebo and to investigate the long-term tolerability of BP-C1 in the treatment of patients with metastatic breast cance...